Twist Bioscience (TWST) Reports Q2 2026 Financial Results
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowTwist Bioscience Corporation (TWST) reported its financial results for Q2 2026. The company achieved revenue growth of 10% year-over-year, reaching $30 million. The gross profit margin for the quarter was reported at 65%. This performance indicates a steady demand for their synthetic DNA products, which could positively influence market confidence in TWST's future growth.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Alphabet (GOOGL) Shares Fall After Q2 Earnings Report
Oct 19
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19